Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Published 18/07/2023, 18:00
© Reuters.  Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga - Gainers

  • Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
  • The Singing Machine Company, Inc. (NASDAQ: MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line available at Walmart.
  • Biophytis S.A. (NASDAQ: BPTS) gained 29% to $2.78 after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.
  • iCAD, Inc. (NASDAQ: ICAD) rose 21.3% to $2.50. iCAD signed strategic commercial agreement with Radiology Partners, the nation's largest radiology practice.
  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares climbed 18.7% to $0.3121 after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients.
  • Interlink Electronics, Inc. (NASDAQ: LINK) shares climbed 17.4% to $12.65.
  • Innodata Inc. (NASDAQ: INOD) gained 16.2% to $12.43.
  • D-Wave Quantum Inc. (NYSE: QBTS) climbed 15.1% to $2.9585. Benchmark, on Monday, maintained a Buy rating on the stock and raised its price target from $2 to $3.
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 14.4% to $0.9595.
  • Advanced Emissions Solutions, Inc. (NASDAQ: ADES) rose 13.4% to $1.8061. Advanced Emissions Solutions named Robert Rasmus to succeed Greg Marken as President and CEO on July 17, 2023.
  • Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 13.4% to $5.26 in pre-market trading after jumping 27% on Monday.
  • Altice USA, Inc. (NYSE: ATUS) rose 13% to $3.3106. Altice USA named CEO Dennis Mathew as Chairman.
  • Hyperfine, Inc. (NASDAQ: HYPR) climbed 12.8% to $2.64.
  • Astronics Corporation (NASDAQ: ATRO) gained 12.6% to $20.89. Astronics reported above-consensus second-quarter preliminary revenue results.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) climbed 12.3% to $4.0250.
  • The Charles Schwab Corporation (NYSE: SCHW) gained 12.2% to $65.79 following better-than-expected second-quarter results.
  • PacWest Bancorp (NASDAQ: PACW) climbed 11.5% to $9.19.
  • Rubicon Technologies, Inc. (NYSE: RBT) shares rose 10% to $0.4312 after surging 19% on Monday.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) gained 9.7% to $4.65.
  • Mercantile Bank Corporation (NASDAQ: MBWM) rose 9.7% to $32.31 after the company posted upbeat second-quarter results and raised quarterly dividend.
  • iSun, Inc. (NASDAQ: ISUN) shares climbed 9.1% to $0.43.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) shares fell 67.1% to $0.2045 after the company announced on July 17th it, along with its subsidiaries, ceased operations and filed a voluntary petition for relief under the Bankruptcy Code.
  • Fangdd Network Group Ltd. (NASDAQ: DUO) declined 29% to $0.2803. Fangdd Network announced an $8 million registered direct offering of 11,428,565 shares at a purchase price of $0.70 per share.
  • Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) fell 26.2% to $5.56 after the company announced pricing of a $3.5 million registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules.
  • Masimo Corporation (NASDAQ: MASI) dipped 21.8% to $115.01 after the company reported weak preliminary revenue results for the second quarter.
  • AERWINS Technologies Inc. (NASDAQ: AWIN) fell 21.4% to $0.3524.
  • Gorilla Technology Group Inc. (NASDAQ: GRRR) shares declined 21.2% to $2.9985.
  • Aptevo Therapeutics Inc. (NASDAQ: APVO) declined 21.1% to $1.12 after the company released duration of remission data from Phase 1b expansion trial of APVO436 for Acute myelogenous leukemia.
  • CEL-SCI Corporation (NYSE: CVM) fell 20.6% to $2.27 after the company priced its public offering of 2.5 million shares at $2 per share.
  • UTime Limited (NASDAQ: UTME) tumbled 19% to $0.7780.
  • EUDA Health Holdings Limited (NASDAQ: EUDA) fell 18% to $0.5001.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) fell 15.2% to $44.47.
  • Stryve Foods, Inc. (NASDAQ: SNAX) dipped 14.4% to $7.29.
  • IronNet, Inc. (NYSE: IRNT) fell 14% to $0.1549. IronNet intends to voluntarily delist securities from the NYSE.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) fell 13.6% to $0.70 after declining around 15% on Monday.
  • Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) fell 13.3% to $8.43 after reporting a proposed public offering of common stock.
  • Ryvyl Inc. (NASDAQ: RVYL) declined 13.5% to $1.2705.
  • eXp World Holdings, Inc. (NASDAQ: EXPI) fell 9.2% to $22.35. BTIG initiated coverage on eXp World with a Sell rating and announced a price target of $14.
  • Novan, Inc. (NASDAQ: NOVN) fell 8.8% to $0.1640. Novan shares declined 70% on Monday after the company announced it entered into an agreement to sell substantially all of its assets and filed for Chapter 11 protection.
  • SunCar Technology Group Inc. (NASDAQ: SDA) declined 8.3% to $9.99.
  • FREYR Battery (NYSE: FREY) fell 7.6% to $8.88. Goldman Sachs downgraded FREYR Battery from Buy to Neutral and lowered the price target from $14 to $10.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: J.B. Hunt Transport Likely To Report Lower Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.